The Locust Walk Partners team is thrilled to have just completed our first year in business. While it was a turbulent time for the industry, we are proud of this year’s accomplishments including: Executing nearly 15 client business development, strategic, and...
I am pleased to announce that my partner and co-founder, Jay Mohr, Managing Director of Locust Walk Partners, recently achieved a professional milestone. Jay was founding CEO of Gloucester Pharmaceuticals and was responsible for diligencing and in-licensing Istodax®...
Today we revealed the results of our buy-side BD survey about licensing best practices at the FierceBiotech Webinar titled “Partnering with Pharma: How to Get a Deal”. On the panel with us were Ad Rawcliffe from GSK and Anna Protopapas from...
I had a very interesting conversation on Friday with a business development executive from a major pharmaceutical company (both shall go unnamed to protect confidentiality). He had read my posting about negotiating the exit before the entry and was very intrigued. He...
Jay and I taught a business development class at Wharton this past week as part of the Healthcare Finance class (HCMG 849). We spoke mostly about the process of buying and selling assets combining this with financial analysis modeling to correlate terms in a term...
